secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protara Therapeutics, Inc. (TARA)
CIK:        0001359931
Form:       8-K
Filed at:   2026-06-15T20:05:37+00:00
Accession:  0001213900-26-068774
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Protara shareholders vote to double authorized shares to 200M at annual meeting
-------------------------------------------------------------------------------

- Authorized common stock increased from 100M to 200M shares; 42.4M for, 2.7M against.
- Class III directors elected: Jesse Shefferman, Barry Flannelly, Cynthia Smith.
- Advisory say-on-pay approved (29.2M for); frequency set to every 1 year (26.8M for).
- Amendment to 2024 Equity Incentive Plan approved (18.1M for, 12.8M against).
- Officer exculpation amendment passed (29.6M for, 1.2M against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1359931/000121390026068774/0001213900-26-068774-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1359931/000121390026068774/ea0294030-8k_protara.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-068774

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer